 
                                Alvaro Goyanes
@aggoyanes
Pharmacist and 3D printing enthusiast. Development Director at FabRx. All views my own
ID: 770289732194557952
29-08-2016 15:59:18
171 Tweet
277 Followers
46 Following
 
         
         
        📢Álvaro Goyanes (Alvaro Goyanes) de la Fac. Farmacia USC, analiza en esta entrevista 🎤 el impacto de la #Impresión3D de medicamentos💊 Más seguridad y individualización son algunas de las ventajas. dozz.es/5n4fi2
 
         
         
         
         
         
         
         
         
        Our PI Alvaro Goyanes was the chair of a round table on #3Dprinting XVII Congreso SEFIG Tenerife 2025 with Abdul Basit , Carlos Parrondo and Edu Diaz Torres Eduardo Díaz ediaztor @I+DFarmaUSC iMATUS (Instituto de Materiales de la USC) FABRX Roadmaps to implement 3D printing at hospitals and community pharmacy are on going. 👇👌
 
                        
                    
                    
                    
                 
         
         
         
         
        Step into the future of healthcare and explore the limitless possibilities of 3D printing. Join our event in collaboration with the Academy of Pharmaceutical Sciences: events.rpharms.com/website/16267/ Academy of Pharmaceutical Sciences Abdul Basit Louise Bracken Atheer Awad Steve Tomlin
 
                        
                    
                    
                    
                 
         
        Our co-founders Abdul Basit & Alvaro Goyanes, with Anna Kirstine Jørgensen from UCL, co-authored a key article in ONdrugDelivery on "3D Printing: The Future of Personalised Medicines." Read the full article now: lnkd.in/e56NyRUQ #PersonalizedHealthcare #DrugFormulation
 
                        
                    
                    
                    
                 
         
                         
                         
                         
                         
                         
                         
         
                         
                         
                         
                         
                         
                        